Amplify Weight Loss Drug & Treatment ETF

Shareclass
Amplify Weight Loss Drug & Treatment ETF (THNR)
Type
Exchange-traded fund

Equity & Justice

Exclusions







EQUITY & JUSTICE RATINGS

Gender Equality
Diversity Disclosures
Racial Justice
LGBTQ+ Equity

GENDER EQUALITY

Fund Amplify Weight Loss Drug & Treatment ETF

FUND COVERAGE
# of holdings15
% of assets88%
Score
58 / 100
Rank

96.8 percentile

Group: Sector Equity

Rank: #29 out of 865

Grade
A

Gender equality ratings are calculated using data from the Equileap Gender Equality Scorecard from Equileap.

Sub-scores & KPIs

Gender Equality: Gender Balance in Leadership and Workforce

29 / 40

Gender Equality: Equal Compensation and Work Life Balance

11 / 30

Gender Equality: Policies Promoting Gender Equality

18 / 20

Gender Equality: Commitment, Transparency, and Accountability

1 / 10

Fund Holdings: Gender Equality

Highest scoring holdings

Highest scoring holdings

Top 10 holdings by Gender Equality score

  • Holding
    % invested
    USD$
  • 1. AstraZeneca PLC ADR
         % of fund invested: 5%
         $USD invested: $128,214
  • 2. Novo Nordisk AS ADR
         % of fund invested: 11%
         $USD invested: $287,610
  • 3. Merck & Co Inc
         % of fund invested: 4.98%
         $USD invested: $127,508
  • 4. Roche Holding AG
         % of fund invested: 4.72%
         $USD invested: $120,944
  • 5. AbbVie Inc
         % of fund invested: 4.89%
         $USD invested: $125,155
  • 6. Amgen Inc
         % of fund invested: 6.93%
         $USD invested: $177,566
  • 7. Regeneron Pharmaceuticals Inc
         % of fund invested: 7.56%
         $USD invested: $193,585
  • 8. Pfizer Inc
         % of fund invested: 4.89%
         $USD invested: $125,222
  • 9. Zealand Pharma AS
         % of fund invested: 3.41%
         $USD invested: $87,394
  • 10. Eli Lilly and Co
         % of fund invested: 14%
         $USD invested: $360,675
Lowest scoring holdings

Lowest scoring holdings

Bottom 10 holdings by Gender Equality score

  • Holding
    % invested
    USD$
  • 1. Scholar Rock Holding Corp
         % of fund invested: 1.49%
         $USD invested: $38,091
  • 2. CSPC Pharmaceutical Group Ltd
         % of fund invested: 3.69%
         $USD invested: $94,491
  • 3. Hims & Hers Health Inc Ordinary Shares - Class A
         % of fund invested: 4.33%
         $USD invested: $110,922
  • 4. Chugai Pharmaceutical Co Ltd
         % of fund invested: 6.61%
         $USD invested: $169,299
  • 5. Shionogi & Co Ltd
         % of fund invested: 4.58%
         $USD invested: $117,231
  • 6. Eli Lilly and Co
         % of fund invested: 14%
         $USD invested: $360,675
  • 7. Zealand Pharma AS
         % of fund invested: 3.41%
         $USD invested: $87,394
  • 8. Pfizer Inc
         % of fund invested: 4.89%
         $USD invested: $125,222
  • 9. Regeneron Pharmaceuticals Inc
         % of fund invested: 7.56%
         $USD invested: $193,585
  • 10. Amgen Inc
         % of fund invested: 6.93%
         $USD invested: $177,566

Fund manager statement

We invite fund managers to take our survey and provide more information on how they integrate principles of justice and equity in their investment strategy.

Manager survey




EXCLUSION RATINGS

Prisons & Borders
Military Weapons

PRISONS & BORDERS

Fund Amplify Weight Loss Drug & Treatment ETF

Totals

Holdings
Assets
Weight
Prisons
0
$0
0%
     Prisons high risk
0
$0
0%
     Private prisons
0
$0
0%
Borders
0
$0
0%
     Borders high risk
0
$0
0%
Total
0
$0
0%
Full fund results

Holdings — 0 flagged holdings

More from Invest Your Values
See how mutual funds and ETFs are rated on issues ranging from fossil fuels, to deforestation, gender equality, guns, prisons, weapons, and tobacco

Disclaimer: As You Sow is not an investment adviser

As You Sow is not an investment adviser as that term is defined under federal and state (California) laws and regulations. As You Sow is a tax-exempt, nonprofit organization dedicated to educating and empowering shareholders to change corporations for the good through the collection, analysis and dissemination of relevant information to the public, free of charge. As You Sow does not provide financial planning, legal or tax advice. Nothing on this website shall constitute or be construed as an offering of financial instruments, or as investment advice or investment recommendations.
See our full disclaimer